Zometa



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Metastases To Bone 29.2%
Multiple Myeloma 15.7%
Breast Cancer 11.9%
Prostate Cancer 7.5%
Breast Cancer Metastatic 7.2%
Prostate Cancer Metastatic 5.4%
Pain 4.3%
Osteoporosis 3.7%
Hypertension 3.0%
Neoplasm Malignant 2.0%
Depression 1.3%
Prophylaxis 1.3%
Hypercalcaemia 1.2%
Lung Neoplasm Malignant 1.0%
Bone Disorder 1.0%
Diabetes Mellitus 1.0%
Hypercalcaemia Of Malignancy 0.9%
Renal Cell Carcinoma 0.8%
Plasma Cell Myeloma 0.8%
Metastatic Renal Cell Carcinoma 0.8%
Osteonecrosis 21.9%
Tooth Extraction 13.2%
Death 12.4%
Osteonecrosis Of Jaw 12.3%
Pain 5.7%
Weight Decreased 4.7%
Toothache 4.1%
Pain In Jaw 3.0%
Vomiting 2.9%
White Blood Cell Count Decreased 2.4%
Osteomyelitis 2.2%
Terminal State 2.1%
Neoplasm Malignant 1.9%
Swelling 1.8%
Tooth Loss 1.8%
Pyrexia 1.7%
Wound Debridement 1.6%
General Physical Health Deterioration 1.5%
Tooth Disorder 1.5%
Surgery 1.3%
Secondary
Metastases To Bone 19.2%
Multiple Myeloma 15.5%
Breast Cancer 13.1%
Prostate Cancer Metastatic 8.2%
Breast Cancer Metastatic 7.4%
Osteoporosis 5.8%
Pain 4.8%
Prostate Cancer 4.0%
Product Used For Unknown Indication 3.7%
Hypertension 3.0%
Depression 2.8%
Prophylaxis 2.4%
Drug Use For Unknown Indication 1.9%
Neoplasm Malignant 1.7%
Hypercalcaemia 1.5%
Plasma Cell Myeloma 1.1%
Bone Loss 1.1%
Bone Disorder 1.0%
Anaemia 0.9%
Anxiety 0.9%
Tooth Extraction 11.6%
Weight Decreased 10.7%
Death 9.8%
Osteonecrosis 9.0%
Terminal State 8.5%
Pain 7.7%
Osteonecrosis Of Jaw 6.3%
Vomiting 6.0%
Toothache 4.4%
General Physical Health Deterioration 3.8%
Neoplasm Malignant 2.8%
Wound Drainage 2.5%
Wound Debridement 2.4%
X-ray Abnormal 2.2%
Wound Dehiscence 2.1%
Pain In Jaw 2.1%
Fatigue 2.1%
Pneumonia 2.1%
Weight Increased 2.0%
Pyrexia 1.9%
Concomitant
Product Used For Unknown Indication 19.7%
Multiple Myeloma 15.4%
Drug Use For Unknown Indication 13.9%
Prophylaxis 9.8%
Prostate Cancer 4.2%
Breast Cancer 4.0%
Hypertension 3.9%
Pain 3.9%
Plasma Cell Myeloma 3.6%
Metastases To Bone 3.4%
Breast Cancer Metastatic 2.9%
Constipation 2.2%
Metastatic Renal Cell Carcinoma 2.2%
Cancer Pain 2.1%
Non-small Cell Lung Cancer 1.8%
Nausea 1.8%
Prostate Cancer Metastatic 1.4%
Renal Cell Carcinoma 1.4%
Diabetes Mellitus 1.2%
Insomnia 1.0%
White Blood Cell Count Decreased 9.2%
Death 9.0%
Vomiting 8.7%
Pneumonia 7.7%
Weight Decreased 7.6%
Pyrexia 6.5%
Thrombocytopenia 6.4%
Sepsis 4.7%
Rash 4.3%
Renal Failure 4.2%
Pain 3.8%
Multiple Myeloma 3.5%
Renal Failure Acute 3.4%
Stomatitis 3.3%
Neutropenia 3.1%
Diarrhoea 3.1%
Neuropathy Peripheral 3.1%
Pancytopenia 2.9%
Disease Progression 2.8%
Osteonecrosis 2.8%
Interacting
Metastases To Bone 12.2%
Rectal Cancer 12.2%
Prostate Cancer 10.2%
Adenocarcinoma 6.1%
Breast Cancer 6.1%
Breast Cancer Metastatic 6.1%
Hypertension 6.1%
Bone Disorder 4.1%
Bone Lesion 4.1%
Cardiac Failure 4.1%
Hypercalcaemia 4.1%
Multiple Myeloma 4.1%
Nausea 4.1%
Renal Cell Carcinoma 4.1%
Autoimmune Thyroiditis 2.0%
Breast Cancer Female 2.0%
Fracture 2.0%
Hyperuricaemia 2.0%
Hypothyroidism 2.0%
Lung Neoplasm Malignant 2.0%
Thrombocytopenia 14.3%
Hepatitis Toxic 9.5%
Osteonecrosis Of Jaw 9.5%
Blood Creatinine Increased 4.8%
Drug Interaction 4.8%
Fatigue 4.8%
Hair Metal Test Abnormal 4.8%
Hepatitis 4.8%
Hypokalaemia 4.8%
Nausea 4.8%
Potentiating Drug Interaction 4.8%
Renal Failure Acute 4.8%
Renal Impairment 4.8%
Swelling 4.8%
Tooth Extraction 4.8%
Vomiting 4.8%
Waist Circumference Increased 4.8%